Meier Hsu
YOU?
Author Swipe
View article: A Gut Feeling: Mantle Cell Lymphoma Unveiled by Occult Gastrointestinal Bleeding in a 75-Year-Old Woman: A Case Report and Literature Review
A Gut Feeling: Mantle Cell Lymphoma Unveiled by Occult Gastrointestinal Bleeding in a 75-Year-Old Woman: A Case Report and Literature Review Open
Background Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma that frequently involves extranodal sites, particularly the gastrointestinal (GI) tract. While GI involvement is common in MCL, presentation with overt GI bleedin…
View article: Accelerated osteocytic citrate production in chronic kidney disease is associated with protection of the kidney
Accelerated osteocytic citrate production in chronic kidney disease is associated with protection of the kidney Open
Summary Patients with chronic kidney disease (CKD) face elevated fracture incidences, but mechanisms underlying CKD-related bone loss remain unclear. Using the adenine-induced chronic kidney injury (AdKI) murine model, we identified that A…
View article: Aseptic Meningitis and White Matter Disease in Childhood‐Onset Neuropsychiatric Lupus
Aseptic Meningitis and White Matter Disease in Childhood‐Onset Neuropsychiatric Lupus Open
We reported a 10‐year‐old girl who had an atypical demyelinating disease as the presentation of her neuropsychiatric lupus. The patient had a 4‐year history of systemic lupus erythematosus which had been on remission until she presented wi…
View article: Validation of a Clinical Calculator Predicting Freedom From Colon Cancer Recurrence After Surgery on the Basis of Molecular and Clinical Variables
Validation of a Clinical Calculator Predicting Freedom From Colon Cancer Recurrence After Surgery on the Basis of Molecular and Clinical Variables Open
BACKGROUND: The Memorial Sloan Kettering clinical calculator for estimating the likelihood of freedom from colon cancer recurrence on the basis of clinical and molecular variables was developed at a time when testing for microsatellite ins…
View article: Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case series
Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case series Open
Background: Residual tumor at the proximal or distal margin after esophagectomy is associated with worse survival outcomes; however, the significance of the circumferential resection margin (CRM) remains controversial. In this study, we so…
View article: Data from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
Data from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma Open
Aspirin and celecoxib prevent colorectal adenoma recurrence. Genetic variants in the UGT1A6 enzyme are associated with delayed aspirin metabolism and greater chemopreventive efficacy. We examined the effect of combining aspirin and celecox…
View article: Data from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
Data from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma Open
Aspirin and celecoxib prevent colorectal adenoma recurrence. Genetic variants in the UGT1A6 enzyme are associated with delayed aspirin metabolism and greater chemopreventive efficacy. We examined the effect of combining aspirin and celecox…
View article: Supplementary Table 1 from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
Supplementary Table 1 from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma Open
PDF file - 64K
View article: Supplementary Table 1 from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
Supplementary Table 1 from The Influence of <i>UGT1A6</i> Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma Open
PDF file - 64K
View article: Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
View article: Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Purpose:In patients with locally advanced esophageal adenocarcinoma, response to neoadjuvant therapy strongly predicts survival, but robust molecular predictors of response have been lacking. We therefore sought to discover meaningful pred…
View article: Supplementary Tables from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Supplementary Tables from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways Open
Supplementary Tables 1 and 2
View article: Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
View article: Supplementary Figure 1 from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Supplementary Figure 1 from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways Open
Alterations in esophageal adenocarcinoma in the TCGA dataset, and mapping of alterations onto the RTK-RAS and Cell Cycle pathways.
View article: Data from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Data from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways Open
Purpose:To delineate recurrent oncogenic driver alterations and dysregulated pathways in esophageal adenocarcinoma and to assess their prognostic value.Experimental Design:We analyzed a large cohort of patients with lower esophageal and ju…
View article: Data from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Data from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways Open
Purpose:To delineate recurrent oncogenic driver alterations and dysregulated pathways in esophageal adenocarcinoma and to assess their prognostic value.Experimental Design:We analyzed a large cohort of patients with lower esophageal and ju…
View article: Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
View article: Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
View article: Supplementary Figure 1 from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Supplementary Figure 1 from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways Open
Alterations in esophageal adenocarcinoma in the TCGA dataset, and mapping of alterations onto the RTK-RAS and Cell Cycle pathways.
View article: Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
View article: Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
View article: Supplementary Tables from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Supplementary Tables from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways Open
Supplementary Tables 1 and 2
View article: Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma Open
Purpose:In patients with locally advanced esophageal adenocarcinoma, response to neoadjuvant therapy strongly predicts survival, but robust molecular predictors of response have been lacking. We therefore sought to discover meaningful pred…
View article: Radiologic and histopathologic features of hydrogel sealant after lung resection in participants of a prospective randomized clinical trial
Radiologic and histopathologic features of hydrogel sealant after lung resection in participants of a prospective randomized clinical trial Open
View article: Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy
Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy Open
Up to 50% of patients treated with curative esophagectomy for esophageal cancer will develop recurrence, contributing to the dismal survival associated with this disease. Regional recurrence may represent disease that is not yet widely met…
View article: Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease
Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease Open
View article: Stent Graft Placement for the Treatment of Hepatic Artery Injury in Patients with Cancer: Primary Patency and Clinical Outcomes
Stent Graft Placement for the Treatment of Hepatic Artery Injury in Patients with Cancer: Primary Patency and Clinical Outcomes Open
View article: Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis
Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis Open
Background The impact of transarterial radioembolization (TARE) of breast cancer liver metastasis (BCLM) on antitumor immunity is unknown, which hinders the optimal selection of candidates for TARE. Purpose To determine whether response to…
View article: Translating Telemedicine to Thoracic Surgical Oncological Care: Performance Analysis and Patient Perceptions During the COVID-19 Pandemic
Translating Telemedicine to Thoracic Surgical Oncological Care: Performance Analysis and Patient Perceptions During the COVID-19 Pandemic Open
Objective: The objective is to determine how the COVID-19 pandemic affected care for patients undergoing thoracic surgery for cancer. Background: The COVID-19 pandemic accelerated the adoption of telemedicine. Methods: Characteristics and …
View article: Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma
Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma Open